Investors & Media International Stem Cell Discovers Method to Produce Uncontaminated Liver Cells: New Platform to Produce Various Cell Types Free From Undifferentiated, Potentially Tumorigenic, Cells International Stem Cell to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on June 16 International Stem Cell Corporation Reports First Quarter Revenue of $1.5 Million on Strong Initial Sales of Skin Care Products and Strong Growth of Research Product Sales International Stem Cell Corporation Enrolls First Donor in Program to Create New Parthenogenetic Stem Cell Lines in the United States ISCO Scientists to Present Results of Recent Stem Cell Research on Central Nervous System and Liver Diseases at Annual Meeting of American Society of Gene and Cell Therapy International Stem Cell Corporation Announces Changes to Streamline Management Team International Stem Cell Corporation Launches New Marketing Campaign for Lifeline Skin CareTM Products International Stem Cell Corporation Chairman Presents Summary of Achievements at Annual Shareholders' Meeting International Stem Cell Successfully Completes First Series of Preclinical Testing of Hepatocytes Derived from Human Parthenogenetic Stem Cells International Stem Cell Corporation Updates on Marketing Strategy of its Subsidiary Lifeline Skin Care 18 19 20 21 22 23 24 25 26 27 28 << < > >>
